Research Progress in Banxia Baizhu Tianma Decoction for the Treatment of Hypertension

高血压是临床上常见的一种慢性疾病，同时也是引起心脑血管疾病的重要危险因素，我国高血压患者逐年增加，且越来越趋于年轻化。其发病机制复杂，目前西药降压主要包括β受体阻滞剂、钙离子拮抗剂以及醛固酮受体拮抗剂等，长期服用西药会给患者带来一定的副作用，甚至还会出现耐药性。中医药在治疗高血压方面有着独特的优势，可以多成分、多靶点进行整体调节，半夏白术天麻汤是我国传统的中药方剂，近年来对半夏白术天麻汤的研究越来越深入，本文就半夏白术天麻汤的研究进展进行综述，为以后的深入研究提供参考。Hypertension is a common chronic disease in clinical practice and an important risk factor for cardiovascular and cerebrovascular diseases. In China, the number of hypertensive patients has been increasing annually, with a notable trend toward younger onset. Its pathogenesis is complex. Current western medical approaches for lowering blood pressure mainly include β-blockers, calcium channel antagonists, and aldosterone receptor antagonists. However, long-term use of western medications may cause certain side effects in patients and even lead to drug resistance. Traditional Chinese medicine (TCM) has unique advantages in the treatment of hypertension, as it achieves holistic regulation through multiple components and targets. Banxia Baizhu Tianma Decoction (a traditional Chinese herbal formula composed of Pinellia ternata, Atractylodes macrocephala, and Gastrodia elata, etc.) has been increasingly studied in recent years. This article reviews the research progress of Banxia Baizhu Tianma Decoction to provide a reference for future in-depth studies.